1. Altagracia-Martinez M, Kravzov J, Martínez N, Ríos C, López N. Prussian blue as an antidote for radioactive thallium and cesium poisoning. Orphan Drugs Res Rev. 2012:2;13–21.
2. Thompson DF, Callen ED. Soluble or insoluble Prussian blue for radiocesium and thallium poisoning? Ann Pharmacother. 2004;38(9):1509–14.
3. Prussian Blue (ferric hexacyanoferrate (II)) for treatment of internal contamination with thallium or radioactive cesium. U.S. Food and Drug Administration; 2003 [updated 2012 Dec 11, cited 2015 Aug 27]. Available from: http://www.fda.gov/Drugs/EmergencyPreparedness/BioterrorismandDrugPreparedness/ucm130334.htm
4. National Council on Radiation Protection and Measurements, Knovel (Firm). Management of persons contaminated with radionuclides handbook: recommendations of the National Council on Radiation Protection and Measurements. Bethesda: National Council on Radiation Protection and Measurements; 2009 [cited 2015 Aug 27]. Available from: http://app.knovel.com/web/toc.v/cid:kpMPCRHRN1
5. Dart RC, Borron SW, Caravati EM, Cobaugh DJ, Curry SC, Falk JL, et al. Expert consensus guidelines for stocking of antidotes in hospitals that provide emergency care. Ann Emerg Med. 2009;54(3):386–94.